Enhancement of monocyte antimycobacterial activity by diethyldithiocarbamate (DTC)
Authors:
- M. ErnstMEM. Ernst
- D. von LaerDLD. von Laer
- S. SchwanderSSS. Schwander
- H.-D. FladHFH.-D. Flad
- 31 December 1991
- journal article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 13 (8) , 1067-1072
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Inhibition of HIV progression by dithiocarbThe Lancet, 1990
- Induction of antigen‐specific CD4+ HLA‐DR‐restricted cytotoxic T lymphocytes as well as nonspecific nonrestricted killer cells by the recombinant mycobacterial 65‐kDa heat‐shock proteinEuropean Journal of Immunology, 1990
- A pilot study of diethyldithiocarbamate in patients with acquired immune deficiency syndrome (AIDS) and the AIDS-related complexLife Sciences, 1989
- RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF DITIOCARB SODIUM ('IMUTHIOL') IN HUMAN IMMUNODEFICIENCY VIRUS INFECTIONThe Lancet, 1988
- Pharmacokinetics of diethyldithiocarbamate (imuthiolR)International Journal of Immunopharmacology, 1985
- Intra- and extracellular susceptibility of Mycobacterium avium-intracellulare complex to aminoglycoside antibioticsAntimicrobial Agents and Chemotherapy, 1984